Thus, local tissue control of androgenlevels in conjunction with numerous other factors drive AR-induced transcriptionalresponses. At low circulating androgen levels, DHT binding is favoredover T but at higher relative T concentrations (e.g., eugonadal state),stabilization of the AR is driven by T more than DHT (20). The SRD5A3 gene has also been linked to increased DHT production in hormonerefractory prostate cancer cells (12), and thisgene may be particularly important in metastatic prostate cells, which have been shown toexpress more SRD5A1 and SRD5A3 but significantly less SRD5A2 (13). These enzymes(expressed in the nucleus and cytoplasm of, for example, prostate epithelial cells) (10) are encoded by the 5α-reductasetype 2 (SRD5A2) gene, and polymorphisms of this gene (leading to increased5α-reductase activity and DHT concentrations in prostate) have beenhypothesized to increase risk of prostate cancer (11). Consequently, lower doses of TE are recommended in prepubertal patients , and low doses of TE for short periods (25 mg every 3–4 weeks for 3–4 times) were thought to not result in the advancement of BA or development of pubic hair . In the present study, two patients with 5αRD2 changed their gender to male when they reached adulthood. Among them, four (patients 3, 5, 6, and 7) did not receive androgen treatment, and two received only TE treatment (patients 17 and 18). Figure 2A,B presents the changes in BA–CA levels before and after androgen treatment. The dosage and duration of the medication are documented in Table S2 We used 2.5% DHT gel (Andractim®, Besins Healthcare, Principauté de Monaco), and one dose of DHT treatment was defined as a dosage of 0.1–0.3 mg/kg/day with a maximum dose of 5 mg/day . Sodium, Potassium, and Pump: The Science Behind Electrolytes Balance in Bodybuilding Since the DHT gel is not officially or commercially available in Japan, the administration for the patients has been approved by Institutional Review Board at Keio University Hospital (#12-08). 1) Changing serum levels of pituitary gonadotropins before → during the DHT application, respectively The study involved four Japanese boys with 5αRD2 (Table 1), who showed definite micropenis 6, 7 with minor anomalies of the external genitalia, such mild bifid scrotum (Pt. 1), thickened mid-band of scrotum (Pts. 2 and 4), or bilateral cryptorchidism (Pt. 3). In this report, we describe a longitudinal data for four 5αRD2 patients with isolate micropenis that were treated with transdermal DHT at pre- and post-pubertal stages. DHT-blocking solutions, meanwhile, can cause side effects like skin irritation, itchiness, contact dermatitis, and redness. While early studies show anti-DHT creams to be effective for women, they’re not always recommended. DHT cream is safe for its intended usage, but it shouldn’t be used for hair loss. This could be to achieve an intermediate area between masculine and feminine characteristics, to achieve a more sexually neutral appearance, or to induce some but not all aspects of masculinization or feminization. One such risk, bone density loss, may be reduced with calcium and vitamin D supplementation, bisphosphonates, and weight-bearing exercise. You may report side effects to the FDA at FDA-1088. The hormone testosterone plays crucial roles during male development and puberty and throughout life, as an anabolic regulator of muscle and bone structure and function. Seek suppliers providing third-party clinical studies or in-vitro data substantiating efficacy claims related to hair strength, density, and growth phases (anagen, telogen). Finasteride blocks the conversion of testosterone into a more potent androgen called DHT -- it is commonly used to prevent hair loss on the head (balding). It’s important to note that individual responses can vary, and some patients may experience results sooner or later than these general timelines suggest. However, it’s crucial to maintain open communication with your healthcare provider throughout the treatment process. These simple adjustments resolved the irritation and allowed John to continue his treatment successfully. His doctor advised him to rotate application sites daily and apply a moisturizer after the gel had dried completely. Impaired conversion of T to DHT is responsible for the symptoms of under-masculinized male external genitalia in patients with 5αRD2. DHT is the most potent and principal endogenous androgen in humans and is essential for the normal development of male external genitalia . This gene encodes for the 5-α-reductase type 2 isozyme, which converts testosterone (T) into dihydrotestosterone (DHT) . Therefore, age and the type of androgen used should be carefully considered to minimize the risk of height reduction in these patient groups. There, you’ll also be able to track your hair loss and growth, seeing results in real time. Phase 2 study results show that total testosterone concentrations increased with increasing dose after daily application of 23, 46 and 69 mg Testavan. Figure 1 Mean ± SD serum concentrations of testosterone on day 90 after dose titration of Testavan With large doses of exogenous androgens, spermatogenesis may also be suppressed through inhibition of pituitary follicle stimulating hormone (FSH). During exogenous administration of testosterone to normal males, endogenous testosterone release may be decreased through feedback inhibition of pituitary luteinising hormone (LH). During puberty, children who are genetically male with 5-alpha reductase deficiency experience a lack of facial hair growth. People with this condition have normal testes with normal to high testosterone levels — they just lack androgen receptors. It happens when their ovaries create excess androgens, including testosterone, which leads to increased DHT levels. Fortunately, liquid chromatography tandem mass spectrometry, widely considered gold standard for total testosterone measurement, is now being adopted by some commercial labs. Measurements of prolactin and iron studies are also important aspects of evaluation. The third step in the diagnostic evaluation is to determine whether androgen deficiency is the result of a primary testicular dysfunction or secondary to a hypothalamic or pituitary disorder. To further investigate these issues, the distribution, density, and regulation of neural AR were compared among male and female mice that were intact, gonadectomized, or gonadectomized and given testosterone propionate (TP) through immunocytochemical and Western blot analyses. A series of human androgen receptor (AR) deletion mutants was constructed to study the relationship between the structural domains and their different functions in the AR protein. In conclusion, these data suggest that non-DNA binding dependent AR actions suppress cortical bone growth, which may provide a mechanism to fine-tune the response to androgens in bone. Cortical bone growth was suppressed by DHT in AR DZF2 mice (6% decrease in periosteal and 7% decrease in medullary circumference vs untreated AR DZF2 males). In cultured genital skin fibroblasts, the mutant AR DZF2 has normal ligand binding ability, phosphor-ylates ERK-1/2 in response to 1 min DHT treatment (blocked by the AR antagonist bicalutamide), but has reduced androgen-dependent nuclear localization compared to wildtype (WT). In studies that did not report standard deviation, we applied an estimate of pooled standard deviation of two groups. References and data for each included study were carefully cross-checked to ensure no overlapping data and to maintain integrity of the meta-analysis. Articles that were finally included in this study were chosen based on inclusion and exclusion criteria followed by an evaluation discussion among all investigators. Two independent investigators (HJ Yang and JH Kim) discovered additional studies by manually searching clinical trial databases and reference lists. Given that most patients with 5αRD2 present with clitoromegaly or microphalli, assigning them male gender would require androgen treatment to enlarge the phallus. Of the 19 patients, Patient 7 presented with a mild isolated micropenis and did not undergo androgen replacement therapy. Understanding the effects of androgen treatment on height in patients with 5αRD2 is crucial for the clinical management of children with this condition. Androgen treatment, including testosterone enanthate (TE), is commonly recommended for pediatric patients with under-masculinization, such as those with micropenises. Tenover and colleagues performed the first and longest study demonstrating that normalserum levels of DHT were not required to maintain androgen effects on body compositionand BMD when older, hypogonadal men were treated with either placebo, TE injections, orTE plus finasteride for 3 years (129, 171). And although long-term safety evaluations appropriately powered toassess disease end points (including prostate cancer and urinary retention) are needed toformally evaluate this risk, such studies will be problematic given the challenge ofevaluating DHT effects in the presence of other endogenous androgens, most notably T. Although androgens support the growth, proliferation, and progression of aggressiveprostate cancer, there is no consensus that elevated levels of circulating androgenscontribute to the risk of developing prostate cancer. Despite such high serum DHT levels, DHT gel treatment did notsignificantly increase total, central, or peripheral prostate volumes, as measured byultrasonography, nor was serum prostate-specific antigen (PSA) elevated. Transdermal dihydrotestosterone therapy and its effects on patients with microphallus. Systemic treatment with T also showed an improvement in the FSFI pain score, which was statistically significant in the T group, while only approaching statistical significance in the T + E group. In fact, in an experimental model of ovariectomized rats, treatment with DHT, a non aromatizable AR super-agonist, was able to induce appetitive and receptive behaviors . In this respect we recently demonstrated in animals, for the first time, that T effect on sexual appetite is mediated by a direct activation of AR, thus without any mandatory conversion into estradiol, as previously hypothesized . A significant increase of FSFI desire, orgasm and total scores by T treatment was also observed, as compared to baseline. All the vascular machinery underlying sexual arousal and lubrication is, in fact, closely related to adequate genital vascularization . Patient 17 demonstrated minimal change, while patients 18 and 19 experienced an increase in height SDS for BA (Figure 2D). Patient 8 initially experienced an increase followed by a decrease in height SDS for BA during first treatment, while the second treatment of patient 8 and the fourth treatment of patient 14 showed no change in height SDS for BA (Figure 2C). Except for patient 8 and the fourth DHT treatment of patient 14, all participants who received DHT treatment demonstrated an increase in the height SDS for BA. Changes in the difference between BA and CA and height SDS for BA following DHT and TE treatments. In patient 13 and the third DHT treatment of patient 14, BA–CA even exhibited a decrease (Figure 2A). The treatment is based either on the substitution of dihydrotestosterone (DHT) or exogenous testosterone which will be converted by 5 alpha-reductase type 2 to DHT. Micropenis is a relatively common phenomenon that can occur either in an isolated form or as part of a disorder of male sexual development.1,2 It is defined as an abnormally short and anatomically correct penis. The patients were divided into two random groups, each group received a different drug, the first arm was treated with transdermal dihydrotestosterone (27 patients) and the second arm was treated with testosterone enanthate (22 patients). All patients received a clinical examination including measurement of penis size before and after hormonal treatment. It’s a comparative randomized study of 49 patients with idiopathic micropenis who are followed up in the Endocrinology-Diabetology and Nutrition Department of Mohammed VI University Hospital Center of Oujda, Morocco. Andractim DHT, in addition to not converting to that nasty test-suppressive-estrogen, will not inhibit LH production or testosterone production (1) (2) (3). This is important because estrogen is suppressive of LH production (1), which is of course going to be an aggravating factor in lowering your endogenous testosterone production. Andractim DHT is a non-aromatizing androgen, which as you know, means it doesnt convert to estrogen at all. Call your doctor for medical advice about side effects. If you notice any other effects, check with your healthcare professional. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Some side effects may occur that usually do not need medical attention. Although not all of these side effects may occur, if they do occur they may need medical attention. The hair loss usually happens on the top and frontal regions of your scalp, causing your hairline to recede over time. BPH can cause difficulty with peeing and sexual dysfunction. Benign prostatic hyperplasia (BPH) is a condition in which your prostate grows in size. Effects of transdermal testosterone treatment on clitoral CDU parameters Given the age of the study population and duration offollow-up, this frequency was not substantially different than the general populationtreated with TRT. Numerous transdermal preparations of T are available for the clinical management ofhypogonadal men and include a nonscrotal T patch, T gel preparations of various Tconcentrations, and a T solution applied to the axilla. Only if the sum of T plus DHT were to fall abovethe upper limit of normal for the combined T plus DHT androgen concentration would there bea theoretical safety concern. Circulating levels of DHT in response to TRT do not correlate with those found inandrogen-sensitive tissue (e.g., prostate, adipose, muscle) due to localregulatory mechanisms that tightly control intracellular androgen homeostasis. After 28 days of oral TU administration at a dose of 316 mg TU, BID(equivalent to 200 mg T, BID), the average serum DHT levels increased from a baseline of21 to 110 ng/dL (0.7 to 3.8 nmol/L), and the serum DHT/T ratio increased from 0.09 toapproximately 0.3. The effects of subcutaneous T pellet implants on DHT have been evaluated in asingle-dose, open-label, nonrandomized pharmacokinetic study (76). My hair is important, so I’ll do anything I can to keep it. If your concern is to reduce DHT for hairloss, this “solution” makes no sense. Please post on hairloss sites if you plan on continuing the medication despite your issues. The gel is artificial DHT, and the tablets are as close to artificial DHT as you get orally. You have two options; Andractim (gel) and Proviron (tablets). If the child was born preterm or was low birth weight, and the glans diameter is atleast mm, then as a first choice we give testosterone injections. Working together, the lock and key, unlock the penis development. In severe varieties such a s proximal penile, penoscrotal, scrotal or perineal hypospadias, penis may be small in almost 50% of the cases. The following information includes only the average doses of this medicine. Also, wash the area where you applied the gel with soap and water if you expect to have a skin-to-skin contact with another person. The gel or solution form can be transferred to another person if they touch or rub the skin where the medicine was placed or if some of it remains on your hands. Do not change your dose unless your doctor tells you to. There is no one-size-fits-all when it comes to Testosterone Replacement Therapy but what we can say is that each method is effective at improving low testosterone symptoms in their own right. Contact BMH if you would like to learn more about how to get started with our bespoke testosterone cream. It’s really up to the patient and the doctor to determine the right dose of cream. We have dispenser container options that help you measure your dose accurately and easily. Our testosterone creams are capable of getting your testosterone level in the upper normal range or the range of a healthy 20 year old. This article does state it can almost bring it down to the levels of castration, but that is only on prolonged use. I thought you said that T production would naturually resume after treatment. Thats terrifying, castrate levels!!!! Once again thank you for the great response i have read the article on the clinical trial 2 questions firstly the trial was for a period of 2 years, i will be cycling five days on and 2 days off for a month followed by a month after a months treatment, at which point i will start again, i will do this three times, so a total of 6 months with 3 months on and three months off so i assume the negative impacts will not neccesarily apply to me ????? The unexpected outcomes are difficult to be explained by serum DHT concentrations, which are markedly lower than those in the target tissues where DHT de novo synthesized by 5α-reductase type 2 . 1–3 (Table 2), resulting in apparent small penis for young adults (–2.4 to –3.4 SD in Table 3) . The lack of growth spurt implicates again that in situ DHT production predominantly regulates penile growth, rather than circulating T or DHT supplied from others. 1–3, post-pubertal penile growth was subtle or arrested during adolescence. DHT then binds to hair follicles, causing them to shrink and eventually stop producing hair. This is why the gel is particularly effective when massaged gently into the donor area. It’s a major cause of graft failure in hair transplants. This drug provides non-stop transdermal Dihydrotestosterone distribution for more than 24 hours following skin application. Thus, this equates to 80 doses every 25 mg, and each dose delivers roughly 2.5 mg of steroid into the body. As with Androgel, about 10% of active steroids can effectively make it into circulation in every application. Also, it will not hinder the production of LH and testosterone. DHTtherapy had no effect on levels of the inflammatory markers, namely, high sensitivityC-reactive protein (hs-CRP), ICAM-1, and VCAM-1. At the 3-month time point,mean serum T had decreased from 432 ng/dL (14.98 nmol/L) to 230 ng/dL (7.97 nmol/L) andDHT increased from 42 ng/dL (1.45 nmol/L) to 733 ng/dL (25.24 nmol/L) in the DHT gelgroup. “Newer formulations of oral testosteroneundecanoate for testosterone replacement therapy are indevelopment.” Because this study was small in scope, larger, placebo-controlledstudies should be conducted to confirm these positive findings. Unfortunately, the number of oral studiesidentified by the authors as meeting the a priori inclusion criteria wasvery small (i.e., four), as was the number of subjects per study. Hunter et al. (2017) discuss the molecular pathways regulating AR mRNA and protein levels in different cell types. Interestingly, the expression of the receptor gene is autoregulated by androgens and both up-and down-regulation has been observed. The AR gene is located on the long arm of the X-chromosome and therefore males are hemizygous, while X-inactivation in females results in one active copy of the gene. We did not find any moderating effects of these factors on main treatment effects. To evaluate whether treatment formulation types improved sexual functions, we also conducted subgroup0 0analysis. TRT formulations were testosterone patch, gel, intramuscular (IM), and oral medication (p.o.) and testosterone dosage was 50 mg to 1,000 mg. A systematic review and meta-analysis was conducted using five studies covering 2,056 patients. Andractim gel is a specialized form of testosterone replacement therapy that has gained popularity for its unique properties and targeted effects. This diagnosis led him to explore treatment options, including testosterone replacement therapy like Andractim gel. Andractim gel stands out from other testosterone treatments due to its active ingredient, dihydrotestosterone (DHT), which is the most potent form of testosterone. In this study, androgen receptor (AR) and estrogen receptors ER and ERß were visualized by immunohistochemistry in adult male ... What are the side effects of DHT cream? While serum DHT concentrations arose to 0.20–1.1 ng/mL during the treatment, serum LH and FSH levels were apparently suppressed in Pts. The external genitalia of affected 46, XY patients are in a broad range from predominantly female to male with isolated micropenis , primarily correlated with genotype of the SRD5A2 gene that encodes 5α-reductase type 2 enzyme. Andractim 2.5% gelAndractim 2.5% gel is a synthetic version of a hormone called testosterone. In addition, differences in AR concentrations and steroid-convertingenzymes in the hair follicle also appear to be play a significant role in MAA (156). Male human skin and hair express an abundance of SRD5A type I in sebaceous glands, hairfollicles, sweat glands, and the epidermis, whereas SRD5A type II is expressed in genitalkeratinocytes and hair follicles (150). These results are consistent with those from shorter-term transdermal DHTstudies (60, 103). Consequently, localized mechanisms in skinmaintain concentrations of DHT that are not meaningfully influenced by circulating DHTlevels, probably due to the fact that the DHT concentration gradient favors secretion intoblood (143, 145). Skin possesses all of the requisite steroidogenic capabilities to ensure localhomeostatic control of steroid hormones, suggesting an important paracrine role for T,DHT, and estradiol within the skin, the function of which is poorly understood (143). DHT blockers, on the other hand, have been shown to safely promote hair growth in those with male pattern baldness. Excessive amounts of DHT or high sensitivity to the hormone can lead to an enlarged prostate gland and male pattern baldness. People who are hypersensitive to andractim 2.5% gel or its ingredients should discuss using this medicine with their doctor.What are the side effects of andractim 2.5% gel? Andractim is not available in the UK so has to be imported from abroad.It works by correcting the hormone deficiency, either in a particular part of the body or affecting the body as a whole.How is andractim 2.5% gel used? Rare side effects may occur if the androgen dose is too high, such as mood swings, weight gain, excessive energy, or acne.The other two participants (Patients 5 and 6) requested a gender identity change from female to male after becoming adults.I’m new, but has anyone had any luck using andractim on their scrotum/penis/glans in order to restore length/sensitivity?These actions proceed principally through activation of cytoplasmic kinases and they suggest that in addition to its genomic functions, the androgen receptor also regulates non-genomic processes.Inlater fetal life, androgens induce testicular descent and has a trophiceffect on the external genitalia.It’s a major cause of graft failure in hair transplants.The favorable pharmacokinetic profile and treatment outcomes combined with enhanced tolerability and superior compliance suggests that testosterone gel formulations are a safe and effective treatment in men with hypogonadism. scRNAseq of colonic organoids derived from biopsies taken from healthy human individuals treated with IL22 IPSS questionnaires (19) and blood for serum hormone measurements and chemistries were collected on d 0, 14, 28, and 56 (recovery) and a transrectal prostate ultrasound was performed at baseline. We hypothesized that supraphysiologic increases in serum DHT would not increase intraprostatic DHT and would have little impact on androgen-regulated processes within the prostate. Moreover, recent studies have demonstrated that alterations in serum androgen concentrations do not result in parallel changes in the intraprostatic hormonal milieu (7, 8, 18). It is likely these effects are mediated by a reduction in intraprostatic androgen concentrations because 5α-reductase inhibitors lower both serum and intraprostatic concentrations of DHT considerably (12, 13). Approximately 5% of circulating T is converted to the more potent androgen dihydrotestosterone (DHT) by the enzymes, type I and II 5α-reductase. Conversely, height SDS for BA during TE treatment was reduced before the age of 10; however, it remained similar or demonstrated a more favorable effect after the age of 10 compared with that during the time of treatment initiation. The increase in height SDS for BA during DHT treatment was higher before the age of 6–7 and remained similar at the time of treatment initiation thereafter. During the DHT treatment, height SDS for BA increased or remained similar, whereas TE treatment resulted in a decrease in height SDS relative to BA. You may have low testosterone depending on the symptoms you have, please contact us to find out how we can help. References, sources and studies used alongside our own in-house research have been cited below, most of which contain external clickable links to reviewed scientific paper that contain date stamped evidence. If you think you’re suffering from low testosterone, don’t hesitate to contact us to see how we can help you. Remember, always consult a doctor before purchasing any medication or beginning any treatment. Here we briefly review existing in vivo animal data or endothelialcell culture experiments that explore the role of androgens (most notably, DHT) onendothelial cell function. “Alternate synthetic pathways may have particularclinical significance within prostate tissue.” Inlight of the fact that this study was not powered for CV outcomes, these findings alsomerit confirmation in a larger, well-controlled trial. TU treatment also decreased peripheral and central arterial stiffnessand, concurrently, modestly increased left ventricular ejection fraction. Oral TU significantly increased serum DHTfrom a baseline of 34 to 64 ng/dL (1.17 to 2.20 nmol/L) after 8 weeks. An example of fetal-onset primary hypogonadism with whole gonadal dysfunction istesticular dysgenesis, while fetal primary hypogonadism with Sertolicell–specific dysfunction occurs, for instance, in patients with mutations ofthe FSH receptor (Siegel etal., 2013) or of the AMH gene (Picard et al., 2017). Primary and central hypogonadismsestablished in this period result in a male newborn with micropenis,micro-orchidism, and/or cryptorchidism. The testes differentiate in the first trimester offetal life, independently of LH and FSH, the pituitary gonadotropins.Testicular hormones drive the internal and external genitalia through themale differentiation pathway. Thus, the concept of male hypogonadism should not beequated just to hypoandrogenism but extended to all conditions with decreasedfunction of any testicular compartment (Leydig, Sertoli, and/or germ cells), ascompared to what is expected for the age. Adverseevents were mostly not clinically significant, for example, minor decline inserum HDL and advancement in bone age (Davis et al., 2017; Ross et al., 2017),except for the development of pubic hair and an increased risk of earlygonadarche even if gonadal axis hormone levels were not affected (Davis et al.,2018). Both androgenic and anabolic effects are generally sought whenandrogen therapy is indicated in male patients; however, specific effects may bepursued in certain cases. These patients have male external genitalia, but the insufficientandrogen levels result in micropenis. An easy option for Androgel users not achieving adequate serum testosterone levels would be to increase the dose rather than switching brands. There still remains considerable uncertainty whether testosterone administration can lead to the growth and development of prostate cancer or if prostate cancer cases detected during therapy are coincidental to treatment. The latter, originally designed for scrotaland then for non-scrotal application, have lost patients’ preferenceowing to the relatively high rate of skin irritation (McBride et al.,2015). However,there is no experience in pediatric patients, and its appropriatenessfor those with pubertal delay raises concern owing to its long-actingperiod. The pharmacokinetic profile is morephysiological than that of enanthate or cypionate (Partsch et al., 1995), withless frequently observed supraphysiological levels in the 1st week andsustained physiological levels for at least 10 weeks in adults withhypogonadism (Figure3; Morgentaler et al., 2008; Zhang et al., 1998). Health risks, particularly those related to androgen deprivation without adequate estrogenic replacement, are a concern with partial approaches to hormone therapy. Demasculinization can be produced via partial to full testosterone suppression or blockade using varied doses of antiandrogens, progestogens, and/or gonadotropin-releasing hormone modulators. Appropriate studies have not been performed on the relationship of age to the effects of testosterone topical gel in children. While bottom growth is driven by testosterone levels in the blood, you may not find much growth by applying testosterone cream or gel locally. Dihydrotestosterone (DHT) is a potent androgen that is critical for male genital development, which when applied topically, has been shown to increase penile length with micropenis of varying etiologies. Changes in the anatomical aspects and circulating levels of sex hormonesin males from fetal life through adulthood. However, a potential adverse effect of testosterone gel that should be borne in mind is the transfer risk to children and women upon close contact with the skin. Injectable testosterone esters also result in a high incidence of polycythemia compared with gels due to higher circulating testosterone levels. The favorable pharmacokinetic profile and treatment outcomes combined with enhanced tolerability and superior compliance suggests that testosterone gel formulations are a safe and effective treatment in men with hypogonadism. Baseline assessment of prostate cancer risk is necessary in middle-aged and older men before instituting therapy. • report the development of signs of excessive androgen exposure such as acne or hair modification. • use the cap applicator for hands-free administration to reduce the risk of secondary exposure to testosterone. Testavan should not be prescribed in patients with a major risk of non-compliance with safety instructions (e.g. severe alcoholism, drug abuse, severe psychiatric disorders). The physician should inform the patient carefully about the risk of testosterone transfer and about safety instructions (see below). A notable case in this regard is the ProstateCancer Prevention Trial (1), which evaluated the effectsof 5AR-I treatment but did not directly measure serum DHT in the men treated with finasteride.Instead, serum 5α-androstane-3α, 17β-diolglucuronide, a distal metabolite of DHT, was used as a surrogate measure of intraprostatic DHT(5). This review on dihydrotestosterone (DHT) biology and the clinical implications of serum DHTconcentrations clarifies concepts that are of importance in clinical practice. Nonetheless, the preponderance ofavailable clinical data indicates that modest elevations in circulating levels of DHT inresponse to androgen therapy should not be of concern in clinical practice. To assess the clinical significance ofmodest elevations in serum DHT and the DHT/testosterone (T) ratio observed in response tocommon T replacement therapy, a comprehensive review of the published literature wasperformed to identify relevant data. Andractim gel, with its unique composition of dihydrotestosterone (DHT), has several specific indications in the field of androgen therapy. Andractim gel, a powerful topical testosterone treatment, has been gaining attention in the world of men’s health and hormone therapy. The androgen receptor (AR) plays a central role in the development and progression of prostate cancer (PCa) and antiandrogen therapy is a standard treatment. An improved understanding of the hormonal and molecular consequences of androgen manipulation within the human prostate might help guide future trials designed to assess risks and benefits of these hormonal therapies. Serum and prostate tissue androgen concentrations and prostate epithelial cell gene expression after 4 wk of treatment. To determine the impact of large increases in serum DHT concentrations on intraprostatic androgen concentrations and androgen action within the prostate. The modest increases observed in serum DHT and in the DHT/T ratio observed after TRT areunlikely to be a cause of clinical concern, particularly when viewed in the context ofchanges observed in these parameters for currently marketed T replacement products and thoseunder development for which DHT data are available. Transient high concentrations of TU and DHTU occur after oralTU, and these may also impact circulating DHT (68).However, the impact of this must be considered small given modest increases in DHT afteroral TU at a time of robust levels of TU and DHTU. The oral TU formulation used in these studies was available under the tradenameAndriol®. For these reasons, it is possible that the combination of bicalutamide and a SERM alone might not be a practical option for non-conventional feminizing hormone therapy. It seems logical that with little to suppress the axis, gonadal production and hence circulating levels of testosterone and estradiol may simply continue to rise until they overwhelm bicalutamide and/or the SERM it is combined with and restore negative feedback on the HPG axis. Moreover, endogenous androgens and estrogens are together responsible for maintaining normal homeostatic negative feedback on the hypothalamic–pituitary–gonadal axis (HPG axis) in people assigned male at birth. Consequently, in combination with a SERM, it is possible that testosterone levels will become too high for bicalutamide to block. How to Use Prostate Gel A few studies have shown a goodefficacy of oral testosterone undecanoate in the treatment of adolescentboys with constitutional delay of puberty (Albanese et al., 1994; Lawaetz et al.,2015), but no experience is published for patients withabsent or delayed puberty due to hypogonadism. Only one report exists on the use of a 5%testosterone ointment in boys with micropenis (Arisaka et al., 2001), and onepreliminary study has compared testosterone gel with IM injections inadolescents with constitutional delay of puberty. Schematic of serum testosterone levels in hypogonadal adult malesbefore (time 0) and after having received intramuscularinjections of testosterone undecanoate (1,000 mg) or enanthate(250 mg). Inthese boys, testosterone and gonadotropin levels remain in the prepubertalrange, and androgen treatment may need to be established to induce pubertalchanges in body aspect before a conclusive diagnosis can be made (Palmert & Dunkel,2012; Salonia etal., 2019). Oxandrolone, a non-aromatizable drug withhigher anabolic than androgenic effects, has been used in adolescents withpreserved testosterone production, like Klinefelter syndrome, with positiveeffects on cardiometabolic health and visual, motor, and psychosocial functions.The usual protocols applied for androgen therapy in boys and adolescents arediscussed. Height was measured using a Harpenden Stadiometer (precision, 0.1 cm; the height of patients under 2 years old was measured in a recumbent position). The current study was conducted in accordance with the Declaration of Helsinki to protect the rights of the participants and personal information. In addition, the current retrospective study only analyzed the results obtained from the medical records of the clinic; therefore, the requirement for informed consent from other participants was waived. Informed consent was obtained from all individual participants included in the study. However, the topic of T treatment in women needs other more in-depth research and specifically designed randomized trials are needed to confirm our original findings. Second, we evaluated for the first time the effect of T treatment on haemodynamic ultrasound parameters, which were assessed in basal conditions. Testosterone can be administered by intramuscular injection of long-acting T esters, transdermally by patch or gel and orally as testosterone undecanoate (TU). Proven benefits for older men with low testosterone (T) levels include increases in muscle strength, exercise capacity, bone mineral density (BMD), libido and insulin sensitivity 2,3. While no significant effects on CV risk were observed with either injected or transdermal TRT, the point estimates suggest that further research is needed to establish whether administration by these routes is protective or detrimental, respectively. No significant difference in the elevation of serum testosterone was present between intramuscular or transdermal TRT. However, no studies have addressed CV risk as a function of the route of administration of TRT. We advocate for responsible usage of Andractim Cream, emphasizing the importance of consultation and supervision throughout the treatment journey. See also the pages for testosterone and estrogen. S.T.P. hasreceived support in the form of drug supply for investigator-initiated studies from BesinsHealthcare (Brussels, Belgium) and Abbvie (North Chicago, IL). We acknowledge thatthe available published data are limited by the lack of large, well-controlled studies oflong duration that are sufficiently powered to expose subtle safety signals. Our data are consistent with these, as intraprostatic androgens, including DHT, T, adrenal androgen precursors, DHEA and androstenedione, and androgen-regulated gene expression, were unchanged despite very high serum DHT levels with DHT gel administration. Our data demonstrate that interventions which significantly raise serum DHT concentrations for 1 month and concomitantly lower serum T levels do not result in marked macroscopic or microscopic effects on healthy prostate homeostasis. To test this hypothesis, we conducted a double-blind, placebo-controlled trial of high-dosage transdermal DHT gel administration in healthy men to determine the effect of increases in serum DHT on intraprostatic hormone concentrations and androgen action. If the patient develops a severe application site reaction, treatment should be reviewed and discontinued if necessary. Testosterone should be used with caution in patients with ischemic heart disease, epilepsy and migraine as these conditions may be aggravated. In this case, treatment must be stopped immediately. After switching to Andractim gel, he experienced significant improvements in libido and energy levels within two months. The effects of Andractim gel can vary depending on the condition being treated and individual factors. This section will explore the expected results, factors affecting its efficacy, and how it compares to other testosterone treatments. Understanding the effectiveness of Andractim gel is crucial for both patients and healthcare providers. Proper application and usage of Andractim gel are crucial for maximizing its effectiveness and minimizing potential side effects. Recently, cloning and characterization of several AR co-regulators have allowed for cellular and molecular analysis of many different aspects of androgen physiology and pathophysiology. The AR is a member of the steroid hormone receptor family, which is found in a variety of tissues, and changes throughout development, aging, and malignant transformation. Their biological actions are mediated by a ligand-dependent nuclear transcription factor, the androgen receptor (AR). Over the past two decades evidence has begun to accumulate to implicate androgens, dependent or independent of the AR, in rapid actions at the cellular and organism level. The bound androgen receptor acts as transcription factor and binds to specific DNA response elements in target gene promoters, causing activation or repression of transcription and subsequently protein synthesis. In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. Everyone reacts to everything different, I simply do not know how to use it effectively while also running into risks of it making me worse. Then the effects seemed to tapper off as I used it. Whethertestosterone replacement should be performed during the first 6 months oflife to mimic the neonatal activation of the gonadal axis is unclear; in anycase, replacement would better be done with gonadotropins to promotetesticular effects (Bouvattier et al., 2012; Young et al., 2019). The most usual practice is to give three IM doses of testosterone enanthate25 mg every 3–4 weeks (Hatipoğlu & Kurtoğlu, 2013; Ladjouze & Donaldson, 2019;A. D. Rogol,2005a,b; Wisniewski et al., 2019). It shouldbe stressed that all commercially available androgenic/anabolic agents aredesigned for adults and none is marketed for use in patients below 18 years ofage. DHT is usually applied topically to thetarget organ, for example, the external genitalia in boys with micropenis(Becker et al.,2016), and is particularly useful in patients with defects of5α-reductase (Aydogdu& Swerdloff, 2016; Xu et al., 2017). Therefore, DHT administration results in anincrease in serum DHT and a decrease in testosterone and estradiol,following DHT inhibition at the hypothalamic level of thehypothalamic–pituitary–testicular axis (Cailleux-Bounacer et al., 2009;de Lignieres,1993; Swerdloff et al., 2017). The present study shows that the LNG implants themselves are well-tolerated by men and safe, and might be suitable for replacing part of the testosterone used as injections to reduce the androgen dose during male hormonal contraception. For some androgen-dependent functions testosterone is a pro-hormone, peripherally converted to 5α-dihydrotestosterone (DHT) and 17β-estradiol (E2), of which the levels preferably should be within normal physiological ranges. I saw rat studies that showed andractim gel completely reversed the sexual and psychogenic erection effects of finasteride. In the next section, we’ll explore what Andractim gel is and how it works to address testosterone deficiency. Testosterone is a steroid hormone that belongs to a class of hormones called androgens. This section will explore what testosterone is, why it’s important, and what happens when levels are low. In this comprehensive guide, we’ll delve deep into the world of Andractim gel, exploring its uses, application methods, effectiveness, potential side effects, and much more. As men age or experience certain health conditions, their testosterone levels may decline, leading to a range of symptoms that can significantly impact their quality of life. My dht is just out of range on the low side, 29 ng/dl, my T and free T are on the low end of normal. Hey @tab and @robbo, what kind of bad effects did you get from using a DHT cream? That is what bothers me most, and I am looking to use andractim to reverse that. Something like oral immunotherapy. The major organ to neutralize androgens is the liver. DHT has at least three times the binding affinity for SHBG than testosterone. Androgens circulate in the blood bound to proteins, especially sex hormone binding globulin (SHBG) and albumin. The bulk of androgen production takes place mainly in the Leydig cells of the testes. DHT is a C19 steroid and possesses androgenic activity. There are no dedicated studies undertaken to demonstrate the efficacy and safety of this medicinal product in patients with renal or hepatic impairment. The maximum recommended dose is 69 mg testosterone per day, which is equivalent to 3 pump actuations. However, it should be taken into account that physiologically testosterone levels are lower with increasing age (see section 4.4). These medications suppress testosterone levels by about 95%, or into the normal female range or male castrate range (Aly, 2019). This is a substantial decrease in testosterone levels, but is not quite into the female range. Androgen deprivation can be achieved with high doses of progestogens, which suppress testosterone levels by up to 50 to 70% (Aly, 2019). These include high-dose progestogen therapy, medical and surgical castration with GnRH agonists/antagonists or gonadectomy, high-dose androgen receptor antagonist therapy, and a few other other possibilities. There are multiple ways to achieve androgen deprivation or testosterone suppression in people assigned male at birth. Few placebo-controlled RCTs report both serum T and DHT before and after treatment. Initially, we intended to exclude RCTs that only reported AEs necessitating study withdrawal, however this turned out to be a fine distinction and so we included any RCT that reported CV events by treatment arm. We excluded trials where testosterone secretion was experimentally suppressed prior to initiation of TRT because these studies do not have a true placebo group. Two expert authors searched for and selected the studies, agreed upon the eligibility of each study and extracted information from the selected trials (SB, FY). In the Page et al. (55) study,there was no change in hematocrit after subjects were treated with a DHT gel preparationfor 1 month. Inhibition of SRD5A results in very modest increases, if any,in circulating T (124–126), thus providing a reasonablecontext in which to evaluate the requirement for DHT in maintaining peripheral androgeneffects. T and its metabolites DHT and estradiol have well-known effects on nongonadal tissuesincluding, but not limited to, the prostate. Proper application and usage of Andractim gel are crucial for maximizing its effectiveness and minimizing potential side effects.After washing, spread the gel evenly over the required skin area, let it dry for about five minutes, and then cover it with clothing.DHT is a derivative of testosterone and is responsible for male and female pattern baldness.Androgen regulated genes are not differentially expressed within the prostate in placebo vs. DHT-treated samples.In 2014, the Endocrine Society Clinical Practice Guideline recommended against making a clinical diagnosis of androgen deficiency syndrome in healthy women, since there is a lack of well-defined criteria , as opposed to men .When more than one pump actuation is required to achieve daily dose, the procedure is repeated to the other upper arm and shoulder.This could be to achieve an intermediate area between masculine and feminine characteristics, to achieve a more sexually neutral appearance, or to induce some but not all aspects of masculinization or feminization.Four Japanese boys with isolated micropenis were diagnosed as 5αRD2 by elevated ratios of serum T/DHT, and decreased ratios of urinary 5α/5β-reduced steroid metabolites.The prostate volumes of two patients were variable at 8.1 and 21 cm3, and a sperm cell count of one patient was normal as young adult.If the patient develops a severe application site reaction, treatment should be reviewed and discontinued if necessary. This suggests that percutaneous DHT administration is a relatively safe modality of androgen replacement therapy as far as atherogenicity is concerned. The results clearly show that DHT inhibits LH secretion, as plasma LH levels were decreased, although testosterone, free testosterone, estradiol and free estradiol levels were decreased. You have to stop it absolutely because the more you are on it the longer your body’s natural testosterone levels will be suppressed. I just read your query and from what you have mentioned, it appears that you have tried to apply DHT (dihydrotestosterone) to increase penile size. This medicinal product may pose a risk to the environment, (See section 5.3). The product is available in packs of one multidose container. Testavan is supplied in a multidose container consisting of a metering pump with a laminate foil pouch in a bottle, and is provided with or without a cap applicator with a hygienic lid. Arecent controlled study in older hypogonadal men demonstrated that T therapy for 12 monthsin older men with low T significantly increased volumetric BMD and estimated bonestrength, more in trabecular than peripheral bone and more in the spine than hip (159). However, theeffectiveness of SRD5A therapy likely resides at the level of the hair follicle(i.e., lowered follicular concentrations of DHT) and not a reduction ofcirculating DHT because this has not been shown to correlate with MAA. Studies of topical DHT in hypogonadalor eugonadal men have not reported adverse effects on skin aside from mild irritation dueto the high alcohol content, despite its direct application and sustainedsupraphysiological levels of DHT for up to 24 months (51, 52, 54). In men, androgen levels are highest in the scrotal skin followed by pubicskin and then thigh skin, a pattern paralleled by 5α-reductase and low3α-reductase activity (and thus tissue DHT) (146). Hence the idea to directly apply DHT gel to target areas. Applying DHT gel/cream to chest (breasts) should theoretically at least keep gyno in check. Jemperli (dostarlimab-gxly) injection is an immunotherapy medication used to treat certain advanced or recurrent cancers, specifically those that are mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H). Yervoy (ipilimumab) is an immunotherapy medication used primarily to treat several types of advanced cancer. Kisqali (ribociclib) is a targeted therapy used to treat specific types of breast cancer. No case of overdose with Testavan has been reported in clinical trials. It allows continued monitoring of the benefit/risk balance of the medicinal product. Testosterone may induce virilising effects on the foetus. Clinicians should adjust the dosage individually to ensure maintenance of eugonadal testosterone levels. Testosterone levels should be monitored at baseline and at regular intervals during treatment. Testavan should be used only if male hypogonadism has been demonstrated and if other etiology, responsible for the symptoms, has been excluded before treatment is started. If the gel was touched with the hands during the application procedure, patients should be instructed to wash their hands with water and soap immediately after applying Testavan. To ensure correct dosing, patients should be instructed to prime each new pump before using it for the first time by pressing the pump head all the way down over a tissue paper until gel appears. Therefore, we should recognize the possible negative effects of T therapy in each patient, according to her metabolic and cardiovascular picture.That means a DHT cream will not be useful if you have experienced hair loss.References, sources and studies used alongside our own in-house research have been cited below, most of which contain external clickable links to reviewed scientific paper that contain date stamped evidence.Contact BMH if you would like to learn more about how to get started with our bespoke testosterone cream.So it would show levels as being fine, but in fact the test is actually measuring a frankenstein form of what it’s actually trying to test.TU treatment also decreased peripheral and central arterial stiffnessand, concurrently, modestly increased left ventricular ejection fraction. In clinical research, higher androgen levels have been linked to an increased CV risk in women with polycystic ovary syndrome . With regard to cardio-metabolic safety, no significant differences in the variations of total and HDL, triglycerides, fasting glycemia, fasting insulin, and HbA1c serum levels were found after T therapy. Effect of different treatments for female sexual dysfunction on clitoral artery PSV. Total testosterone levels according to the mean frequency of sexual events in sexually active women treated for FSD. What are the benefits of Prostate Gel? Currently, there is no consensus concerning age specific reference values for testosterone. There is limited experience on the safety and efficacy of the use of Testavan in patients over 65 years of age. Androgens may accelerate the progression of sub-clinical prostate cancer and benign prostatic hyperplasia. • Known or suspected carcinoma of the breast or the prostate A genetic mutation (change) that affects the production of the enzyme can cause low or no levels of DHT. 5-alpha reductase is an enzyme that helps convert testosterone to DHT. Polycystic ovarian syndrome (PCOS) is a hormonal imbalance that affects females. I am taking all of these supplements which increase these levels in the body, then penile balooning where u maintain an erection for an hour or so through sex and or masturbation allows the nutrient rich blood to hit and stimulate the receptors within the penis allowing growth several studies show that just dht alone caused penis growth in transgender men growing there penis here is the study To investigate the efficacy of transdermal dihydrotestosterone therapy on 22 patients with microphallus, we applied dihydrotestosterone gel for 8 weeks to the external genitalia at daily doses of 12.5 mg. Despite the potential benefits of androgen treatment in patients with 5αRD2 and micropenises, few studies have evaluated the long-term effects of androgen treatments, including TE and DHT, on the growth of these patients. The objective of the study was to investigate the effects of dihydrotestosterone (DHT) gel on general well-being, sexual function, and the prostate in aging men. Some potentially major advantages of high-dose bicalutamide monotherapy are that in contrast to marked or full suppression of testosterone levels, bicalutamide monotherapy largely preserves sexual desire and erectile function and likely does not result in infertility. Unlike testosterone, DHT doesn’t play a significant role in maintaining male physiology in adulthood. Levels of DHT are naturally much higher in males because they naturally have more testosterone. This takes place in the genital skin and prostate in males and in the skin in females. As an adult, your body converts about 10% of your testosterone (the main androgen) into DHT each day. DHT affects the sexual development of males throughout their lives, beginning as early as in fetal development. The Magic of Andractim Gel As discussed later, these alternate synthetic pathways, which arenot influenced by circulating DHT, may have particular clinical significance withinprostate tissue.NGS was performed on 70 patients with DSD, of whom 10 participants (14.3%) were identified as having 5αRD2.Today I’m using a low dose of finasterid, but it’s still very potent, and I need androgenic steroids to manage the heavy side effects.PSA velocity of more than 0.4 ng/ml/year, using the PSA level after six months of testosterone administration as the reference, requires further urological evaluation.Testosterone injections are a widely used and effective treatment for individuals experiencing low testosterone.The side effects of this are hyperpigmentation of the skin over the penis and local hair growth.This treatment uses a testosterone-based substance to induce growth. Long-term treatment with testosterone gel has shown a good safety profile with respect to the prostate. Thus, improvement in mood (similar to sexual function) in response to testosterone therapy appears to be dependent on reaching a threshold of serum testosterone that lies in the low normal range. The improvement in mood was observed on day 30 and was maintained with continued treatment for six42 and 36 months.26 The improvement in mood parameters was not dependent on the magnitude of increase in serum testosterone levels. Its unique properties make it a valuable option for certain patients who may not respond well to other forms of testosterone replacement therapy. Andractim gel represents an important tool in the treatment of specific testosterone-related conditions. It is primarily designed for male patients with specific conditions related to testosterone deficiency. While Andractim gel can be an effective treatment for various conditions, it’s crucial to be aware of potential side effects. For oral studies, the mean and individual values for each of the four studies are listed. AEffects of oral TRT on T and DHT concentrations were not statistically analyzed because only four studies were identified that met our a priori inclusionary criteria, which resulted in sufficient data. Only four oral TRT studies were identified that reported both T and DHT, and the data were insufficient for statistical analysis. Specifically, intramuscular TRT elevated serum T and DHT to a roughly similar degree. Elevation of serum DHT, but not T, was significantly affected by TRT administration mode (see Table 3). Androgen regulated genes are not differentially expressed within the prostate in placebo vs. DHT-treated samples. Moreover, we performed quantitative RT-PCR for several well known androgen-regulated genes (androgen receptor, FKBP5, NKX3.1, PSA, ACPP) and found no differences in expression of these genes between the two groups (data not shown). Specific interrogation of known androgen regulated genes, such as KLK3 (PSA), showed similar expression across both treated and untreated samples, with no consistent differences in the DHT-treated subjects (Fig. 3). Unpaired two-sample t tests revealed no gene expression differences between the placebo and DHT gel-treated subjects. Nonetheless, we have been unable to identifyany long-term studies of the impact of dutasteride on cognition in men. These findings raise thepossibility of some androgen selectivity, although a potency or aromatase effect could notbe ruled out (207). In rodents, T but not DHT improves workingmemory in aging male rats (206), whereas in femalerats, T and DHT improved different aspects of cognition. For this very reason,transdermal DHT (199) and a parenteral DHT prodrugDHT-heptanoate (DHT-hp) has been explored as a treatment of spontaneous gynecomastia inmen or adolescent boys (198, 200). How to Get TRT in the UK? A Clinical & Practical Guide DHT deficiency leads to various degrees of undervirilized external genitalia including micropenis, primarily correlated with mutations of the SRD5A2 gene that encodes 5α-reductase type 2. We equip our patrons with comprehensive resources and information, enabling them to navigate the complexities of hormonal therapy with confidence and clarity. Its targeted approach addresses underlying hormonal imbalances, offering hope and relief to individuals grappling with conditions like micropenis and gynecomastia. Your healthcare provider serves as your ally, guiding you through the nuances of hormonal therapy and monitoring your progress closely. Similar increases in hematocrit and hemoglobin might occur with TRT, which is more pronounced with a high dose of testosterone . The most worrying part when starting TRT in male hypogonadism is the effect on the cardiovascular system and the prostate. Also, older men are more sensitive to gonadotropin inhibitory effects of testosterone than younger men . The expression of testosterone receptor is low in the penis of older animals . The ESF is intended to be used as a measure of overall sexual function. The questionnaire of eleven questions about sexual functioning (ESF) is a validated questionnaire used for evaluating sexual function in the Netherlands . It is not intended to be used as a measure of overall sexual function. In addition, the accuracy of the questionnaire might be poor in elderly patients. A small percentage of treated individuals might show increased hematocrit levels above 55%, which in turn might make them prone to erythrocytosis-related problems. • cover the application area with clothing once the gel has dried. • if the gel was touched with the hands during the application procedure, wash hands thoroughly with soap and water after applying the gel. Alcohol based products including Testavan are flammable; therefore avoid fire, flame or smoking until the gel has dried. Prepubertal diagnoses for 5αRD2 were established by serum ratios of T/DHT after human CG stimulation (3,000 U/m2 for three consecutive days and blood sampling on Day 4), and urinary ratios of 5α/5β-reduced steroid metabolites using a gas chromatograph-mass spectrometry. Although generally accepted as a rare cause of micropenis, 5αRD2 were found in 3.7% of Japanese prepubertal boys with isolated micropenis . Micropenis is a heterogeneous condition defined as significantly small penis without genital ambiguity such as hypospadias . DHT deficiency leads to undervirilized external genitalia but normally differentiated testes and Wolffian ducts and normally regressed Mullerian ducts, consistent with an essential role for development of male external genitalia where the enzyme expressed. The second course of DHT treatment underwent at ages of 12–18 year, but unable to normalize SPLs at a range of 6.0 to 7.0 cm (–3.4 to –2.4 SD). Researchers had filed the patent as the Andractim Gel was proven in these studies. Since DHT cannot be converted or altered to estrogen, it is effectively used for BPH treatment. The famous Andractim DHT Gel sold in the market is Dihydrotestosterone or DHT. The less potent, but significant androgen, dehydrepiandrosterone (DHEA) and its sulphated metabolite (DHEA-S) are present in far higher concentrations in blood that bathes peripheral organs than that of T or DHT. These actions proceed principally through activation of cytoplasmic kinases and they suggest that in addition to its genomic functions, the androgen receptor also regulates non-genomic processes. More recent findings have shown that the receptor also mediates non-conventional responses attributed hitherto only to activated growth factor receptors. Andractim gel contains a synthetic hormone, dihydrotestosterone, used to treat hormone deficiencies in children.Moreover, it is important to note that this study was conducted retrospectively, and certain data, such as the effect of androgen treatment on penis size, were collected subjectively.The following side effects are rare and are usually due to the dose being too high, so will disappear when the dosage is reduced.DHT and women’s hair loss do not have as much of a link, as DHT is a male-dominant hormone and tends to only cause androgenic alopecia in men.In elderly men with prostate cancer, bicalutamide monotherapy induces a 1.5- to 2.0-fold rise in testosterone levels, increasing them from about 300–400 ng/dL to about 500–600 ng/dL (an absolute change of about 150–250 ng/dL) (Wiki). It is prescribed in gel form at Great Ormond Street Hospital (GOSH) for children with hormone deficiencies. Dihydrotestosterone (Andractim®) 2.5% gel for topical application DHT, a potent androgen, promotes the development and maintenance of male characteristics. This property may explain its ability to positively influence LH and testosterone levels. This is significant because estrogen can suppress LH production, leading to a decrease in endogenous testosterone levels. Do not store in the fridge.• If the doctor decides that your child should stop using dihydrotestosterone, return any remaining gel to your pharmacist. By applying the gel to the skin, it promotes localized absorption of DHT, helping restore natural male hormone balance. As already discussed above, dihydrotestosterone is a synthetic version of a hormone called testosterone. Dictator or dihydrotestosterone cream is regarded as one of the top male enhancements. Dihydrotestosterone or DHT cream is an androgenic hormone that is derived from Testosterone. Median serum concentrations of androstenedione and Twere significantly elevated in women with PIH vs controls. These studies were performed before more accurate and precisemeasurements of DHT were possible with LC-MS/MS. Hirsutism, a common symptom of PCOS, is another example where circulating levels of DHT (orits 3α- and 3β-androstanediol metabolites) do not appearto play a significant role compared with intracellular concentrations (232–234). But unlike T and free T that peak at midcycle, DHT levels did not changeacross the menstrual cycle. Because the concentration of DHT is very high in the prostate,one may hypothesize that if DHT stimulates telomere lengthening in prostate, it mayparadoxically play a protective role in some cells. It would seem that if we are able to downward express the AR receptor to the point of where it was before Finasteride use, we might have a fighting chance at getting our receptor/androgen levels back to balance and have them fire like they are supposed to again. The downstream effects also affect the gastro-intestinal system, as well as fundamental aspects of the body like forming correct levels of essential/non-essential amino acids. My experience with doctors has been largely disappointing, everyone seems to want to attack it as a hormonal imbalance issue; and while there are people out there where hormone supplementation will help, it’s pretty much clear at this point that the root of our issue isn’t a mere hormone or two. Dihydrotestosterone 2.5% gel is for external use only. Hi dooes anybody know where to buy Dht gel (andractim) and HCG ?